A Compound I Mimic Reveals the Transient Active Species of a Cytochrome P450 Enzyme: Insight into the Stereoselectivity of P450‐Catalysed Oxidations. Issue 13 (25th January 2023)

• Record Type: Journal Article
• Authors: Suzuki, Kazuto; Stanfield, Joshua Kyle; Omura, Keita; Shisaka, Yuma; Ariyasu, Shinya; Kasai, Chie; Aiba, Yuichiro; Sugimoto, Hiroshi; Shoji, Osami
• Is Part Of: Angewandte Chemie international edition. Volume 62:Issue 13(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2023-01-25
• Subjects: Asymmetric Catalysis -- Crystallography -- Cytochrome P450 -- Decoy Molecules -- Reaction Mechanisms; Chemistry -- Periodicals; 540
• DOI: 10.1002/anie.202215706
• Languages: English
• ISSNs: 1433-7851

Abstract

Abstract: Catching the structure of cytochrome P450 enzymes in flagrante is crucial for the development of P450 biocatalysts, as most structures collected are found trapped in a precatalytic conformation. At the heart of P450 catalysis lies Cpd I, a short‐lived, highly reactive intermediate, whose recalcitrant nature has thwarted most attempts at capturing catalytically relevant poses of P450s. We report the crystal structure of P450BM3 mimicking the state in the precise moment preceding epoxidation, which is in perfect agreement with the experimentally observed stereoselectivity. This structure was attained by incorporation of the stable Cpd I mimic oxomolybdenum mesoporphyrin IX into P450BM3 in the presence of styrene. The orientation of styrene to the Mo‐oxo species in the crystal structures sheds light onto the dynamics involved in the rotation of styrene to present its vinyl group to Cpd I. This method serves as a powerful tool for predicting and modelling the stereoselectivity of P450 reactions. Abstract : Obtaining snapshots of cytochrome P450s with their substrates in catalytically relevant poses has been a longstanding challenge. By exploiting the properties of a synthetic porphyrin that closely mimics the highly unstable P450 active species, styrene could be captured in poses that align with the experimental evidence. This approach shows great promise as a tool in the targeted design of more efficient P450 biocatalysts.